LifeMap Solutions is developing an mHealth platform that integrates disparate sources of information to generate an increasingly accurate picture of an individual's health.
LifeMap Solutions has announced a $5 million seed round led by parent company LifeMap Sciences, a subsidiary of BioTime, Inc., with additional participation via in-kind support from its development partner, The Icahn School of Medicine at Mount Sinai. LifeMap Solutions is building a comprehensive mHealth platform that will utilize a variety of big data sources to construct a holistic picture of an individual's health. This platform will function as a next-generation mHealth operating system, integrating health, wellness, and genetic information into a secure, cloud-based system.
Click the arrow below to learn more.